NCT05633628Recruiting
Periodic Continuous Glucose Monitoring in Patients With Type 2 Diabetes
Periodic Continuous Glucose Monitoring to Support a Person-centered Approach During Diabetes Consultations in Patients With Type 2 Diabetes- A Randomised Controlled Study
Source: ClinicalTrials.gov · Last updated 29 Apr 2026
Brief summary (registry, in English)
The aim of this randomised controlled trial is to investigate the effectiveness of periodic CGM (continuous glucose monitoring) to support a person-centered approach versus self-monitoring of blood glucose (SMBG) in adults with type 2 diabetes on glucose control and patient reported outcomes.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- First submitted
- 21 Nov 2022
- Start date
- 1 Feb 2023
- Primary completion date
- Dec 2026
- Lead sponsor
- Sophiahemmet University
- Diseases
- Type 2 diabetes
- NCT number
- NCT05633628
What you commit to
- Study type: Interventional
- Planned participants: 400
- From 1 Feb 2023 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Planned or currently using weight reduction medications, programs, or surgery
Other illness
- Active malignancy or under investigation for malignancy
- Severe visual impairment
- Eating disorders
Lab values
- Renal disease with estimated glomerular filtration rate (eGFR) \<45 mL/ min/1.73 m2
- Severe skin allergy that inhibits the use of a continuous glucose monitoring device
Other
- Prandial insulin
- Pregnancy or planning pregnancy during the study
- Breastfeeding
- Glucocorticoids (systemic)
- Cognitively or psychologically unable to participate and read instructions
- Enrolled in other clinical trials
Who the study is looking for
- Adults aged 18-80 years
- Type 2 diabetes with a duration of \> 6 months
- HbA1c 45-70 mmol/mol
- Have a smartphone
- Experience of self-monitoring of blood glucose prior to the study start
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sophiahemmet University Coordinator of this site? Confirm its status | Stockholm | Sweden | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.